📰 Cloud Analysis News
Page 2 - Cloud Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cloud Analysis. Real-time updates on events, politics, business and more.
November 2, 2022
/PRNewswire/ -- The "Organ on a Chip Market - Focus on Products and Technologies - Distribution by Type of Product based Models and Disease based Models),...
June 21, 2022
/PRNewswire/ -- The "DNA Synthesis Technologies and Services Market, Distribution by Method of DNA Synthesis, Key Applications Areas, Company Size, and Key...
June 15, 2022
/PRNewswire/ -- The "Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease...
March 22, 2022
/PRNewswire/ -- The "Exosome Development and Manufacturing Services Market, 2022-2035" report has been added to ResearchAndMarkets.coms offering. The "Exosome...
March 21, 2022
/PRNewswire/ -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases...
August 18, 2021
BMW-(Turbo)-Calls mit gehebelten Renditechancen () | aktiencheck.de
April 6, 2021
Share this article Share this article ResearchAndMarkets.coms offering. Since the approval of Vitravene (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development. Examples of recently approved antisense therapeutics include (in reverse chronological order) Viltepso (duc...